Form 4 for HCA HCA Healthcare
Accepted 2024-09-12 00:00:00 ET · period of report 2024-09-10 · accession 0000950170-24-106008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-09-12 | 2024-09-10 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $386.43 | -13.7K | 38.0K | -27% | -$5.30M |
| DT | 2024-09-12 | 2024-09-10 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $145.24 | +22.1K | 51.8K | +74% | +$3.21M |
| DT | 2024-09-12 | 2024-09-12 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale+OE | $385.42 | -8,358 | 29.7K | -22% | -$3.22M |
| DT | 2024-09-12 | 2024-09-10 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $0.00 | -22.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-10 | F | D | 13,722 | $386.43 | 38,036.21 | D | — | — | (F2) Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans. |
| 2 | Common | Common Stock | 2024-09-10 | M | A | 22,080 | $145.24 | 51,758.21 | D | — | — | (F2) Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans. |
| 3 | Common | Common Stock | 2024-09-12 | S | D | 8,358 | $385.42 | 29,678.21 | D | — | — | (F2) Includes 2,518.2085 shares acquired under the Issuer's employee stock purchase plans. |
| 4 | Derivative | Stock Appreciation Right | 2024-09-10 | M | D | 22,080 | $0.00 | 0 | D | $145.24 · — to 2030-01-29 | 22,080 Common Stock | (F3) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021. |